News Releases
Bachem News & Events
Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.
More News Releases by Bachem
-
News Releases
[WEBINAR] High-Resolution Mass Spectrometry Of Oli
Airing on Thursday, December 8 and again on Monday, December 12.443916 11.17.22
-
News Releases
[WEBINAR] Beyond Automation: Towards a Smart Facto
Airing on Thursday, November 17 and again on Tuesday, November 22.443908 11.17.22
-
News Releases
A World of Virtual Reality: Entering the Metaverse
Bachem’s virtual showroom sets industry standards in digital customer experience.443896 11.17.22
-
News Releases
Bachem Expands Presence in Northwestern Switzerlan
The acquired site offers space for further expansion steps to increase the production capacity of the Bachem Group.443897 11.17.22
-
News Releases
Innovative Processes Transforming Oligonucleotide
Bachem invested in a capacity expansion for large-scale production of oligonucleotide APIs442293 10.21.22
-
News Releases
Process-Scale MCSGP Purification of Large Syntheti
Register now for Bachem's webinar on Thursday, 10th November 2022 - 17:20 - 18:30 Europe/Zurich442111 10.19.22
-
News Releases
Beyond Automation: Towards a Smart Factory
Register for Bachem's webinar on Thursday 17th November 2022 - 17:30 Europe / Zurich442108 10.19.22
-
News Releases
Bachem Expands Presence in Northwestern Switzerlan
New production site planned in Sisslerfeld.441500 10.07.22
-
News Releases
[WEBINAR] Towards More Sustainable Procurement
Learn about Bachem's initiatives directed at making their supply chain more sustainable and resilient.440642 09.23.22
-
News Releases
Bachem Signs Large Volume Contracts for Peptides
Two contracts signed with order volumes of CHF 25 million in 2023 and CHF 150 million in 2024.440640 09.23.22
-
News Releases
Interview with Phillip Karbach, COOO/CFO of AMW
We sat down with Philipp Karbach, COO and CFO of AMW, to ask about his experience collaborating with Bachem.440240 09.16.22
-
News Releases
Bachem’s Journey to Industry 4.0
Industry 4.0 refers to the automation and digitalization of traditional industrial processes through smart technology and integration.440236 09.16.22
-
News Releases
Bachem Enters Strategic Collaboration With Lilly T
Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology.406465 05.10.22
-
News Releases
No More DMF: Greener Solid-Phase Peptide Synthesis
Register now for the webinar on Thursday, May 12th at 5:30pm CET / 8:30am PST.405047 04.20.22
-
News Releases
WEBINAR: The Use of Enzymes in the Production of P
Learn in this webinar how enzymes enable greener peptide syntheses and what questions appear around the use of enzymes in a GMP setting.403555 03.29.22
-
News Releases
-
News Releases
-
News Releases
Bachem reports excellent results for the first hal
Sales of CHF 500 million are now expected for the year 2021.388773 09.01.21
-
News Releases
Propofol – A Bachem Success Story
The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.388215 08.24.21
-
News Releases
Bachem and Novo Nordisk Redesign SPPS for Green Ch
Replacing gold standard solvents to provide a greener alternative.388206 08.24.21
More Content From Bachem
-
Bachem's Key Ingredients for a Successful Oligonucleotide Drug Development
Bachem drives innovation and invests into new oligo manufacturing capacities to meet the needs of our customers.White Papers / Tech Papers Released on 11.17.2022
-
Exclusive Services for Cosmetic Peptides
Peptides are popular active ingredients for cosmetic products called cosmeceuticals.Services Released on 09.16.2022
-
Innovation Transforming Oligonucleotide Manufacturing
One of Bachem’s mission is to provide excellence to its customers and be a major player in their success.Services Released on 07.05.2022
-
Risk Assessment for a Nitrosamine Contamination of Peptide APIs Manufactured by SPPS
This webinar will focus on Bachem's approach to execute the risk assessment for peptides produced by SPPSVideos Released on 05.25.2022
-
Bachem - Partner from Research to Marketed API
Bachem is the world’s leading company in the development and production of peptides and oligonucleotides (TIDES).Literature / Brochures Released on 05.10.2022
-
Bachem's New Facilities For Large-Scale Oligonucleotide Manufacturing Suppliers
Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.Company Blog Released on 04.20.2022
-
Cell-Penetrating Peptides: A Delivery System For Oligonucleotides
Oligonucleotides are very promising and versatile therapeutics for rare and genetic diseases.Literature / Brochures Released on 03.21.2022
-
Oligo Therapeuticas - Innovation that Transforms Lives
Welcome to the Future.Literature / Brochures Released on 03.09.2022
-
Oligonucleotides - Innovation that transforms lives
Emerging as a new treatment option in rare and orphan disease areas, oligonucleotides have matured into a drug class with a broad indication spectrum.Videos Released on 03.09.2022
-
Bachem - The Perfect Ingredients for a Better World
What ingredients make Bachem a world-leading specialist for drug substances and a partner for pharma & biotech across the globe?Videos Released on 03.09.2022
-
The thiol-maleimide reaction downside
Secrets of an important byproduct revealedCompany Blog Released on 03.04.2022
-
[WEBINAR] Trends in Peptides and Oligonucleotides – Choosing a Bartner CDMO
This webinar which will take you through the foreseeable future of peptides and oligonucleotides.Videos Released on 02.01.2022
-
Do it Right, by Not Doing it Yourself – the Value of a Good CDMO Partner
Partnering with a specialized CDMO can have many advantages especially for complex API like peptides or oligonucleotides.Videos Released on 01.03.2022
-
How are peptides made?
Peptides are very interesting molecules for many applications from therapeutics to cosmetics and diagnostics. But how are they made?Literature / Brochures Released on 10.06.2021
